Abstract | BACKGROUND: METHODS: In this randomized, triple-blind, placebo-controlled trial, women with PMS and dysmenorrhea were divided randomly into experimental and control groups to receive one capsule (500 mg of curcuminoid+ 5 mg piperine, or placebo) daily, from approximately 7 days before until 3 days after menstruation for three consecutive menstrual cycles. Serum vitamin D levels, renal function, and liver enzymes were also measured before and after intervention. RESULTS: A total of 76 subjects (38 in each group) were recruited into the trial. Curcumin significantly increased the median (IQR) serum levels of vitamin D [from 12.8 ng/ml (7.0-24.6) to 16.2 ng/ml (6.4-28.8); P = 0.045], compared with placebo [from 18.6 ng/ml (2.2-26.8) to 21.3 ng/ml (5.2-27.1); P = 0.17]. Serum levels of aspartate aminotransferase and direct bilirubin were reduced by the end of trial in the curcumin group (p < 0.05), but did not change significantly in the control group (p > 0.05). Finally, no significant differences in levels of fasting blood glucose were detected between curcumin and placebo groups. CONCLUSION: TRIAL REGISTRATION: The trial was registered on Iranian Registry of Clinical Trials registry (Trial ID: IRCT20191112045424N1 on 23 January 2020; available at https://www.irct.ir ).
|
Authors | Leyla Arabnezhad, Mahtab Mohammadifard, Ladan Rahmani, Zahra Majidi, Gordon A Ferns, Afsane Bahrami |
Journal | BMC complementary medicine and therapies
(BMC Complement Med Ther)
Vol. 22
Issue 1
Pg. 19
(Jan 22 2022)
ISSN: 2662-7671 [Electronic] England |
PMID | 35065636
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- Vitamin D
- Aspartate Aminotransferases
- Curcumin
- Bilirubin
|
Topics |
- Aspartate Aminotransferases
(blood)
- Bilirubin
(blood)
- Curcumin
(pharmacology, therapeutic use)
- Dietary Supplements
- Dysmenorrhea
(drug therapy)
- Female
- Humans
- Premenstrual Syndrome
(drug therapy)
- Research Design
- Vitamin D
(blood)
- Young Adult
|